Bristol-Myers Squibb Company: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-07-05
Other years: 2026 vs 2025 · 2025 vs 2024
✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
0
Removed
7
Modified
15
Unchanged
🟢 New in Current Filing Expectations relating to environmental, social and governance considerations and related reporting obligations expose the Company to potential liabilities, increased costs, reputational harm, and other adverse effects on the Company’s business. 🔒
🟡 Modified Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins. 🔒
🟡 Modified We are dependent on information technology systems and face risk of cybersecurity incidents that could disrupt our business and result in theft of proprietary and confidential information. 🔒
🟡 Modified We are subject to a variety of U.S. and international laws and regulations. 🔒
🟡 Modified We depend on several key products for most of our revenues, cash flows and earnings. 🔒
🟡 Modified Changes to tax regulations could negatively impact our earnings. 🔒
🟡 Modified We have significant indebtedness that could have negative consequences. 🔒
🟡 Modified Third-party royalties represent a significant percentage of our pretax income and operating cash flow. 🔒
8 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →